UPDATED SEPTEMBER 25, 2026 · 1642 STORIES ON THE WIRE

The world,
before your
first coffee.

NewsDialy is the 6 AM markets brief that lands before the open. Five stories, a two-minute read, zero noise — so you walk into the trading day already ahead of it.

Free forever · No spam · Unsubscribe in one click

Today's front page

Three on the wire.
Read in ninety seconds.

See the full desk

Latest from the desk

Freshly filed.
Ready before the bell.

See the full desk
04DEALS

ESPN faces Aikman contract impasse before Super Bowl debut

ESPN is preparing to broadcast its first Super Bowl this February with Joe Buck and Troy Aikman at the microphone, yet the future of that pairing remains uncertain. While Buck recently secured a six-year, $108 million contract extension…

SEPTEMBER 24, 20262 MIN
05EARNINGS

Ole Miss student identified as narcotics task force probes two deaths

Robert Strang, a 20-year-old from Atlanta, has been identified as one of two University of Mississippi students found dead under suspicious circumstances in recent days. His family's attorney confirmed the identification to Fox News…

SEPTEMBER 24, 20262 MIN
06CRYPTO

FanDuel Offers $250 Bonus for Packers-Falcons Game

FanDuel Sportsbook is offering new users $250 in bonuses for betting on the Green Bay Packers and Atlanta Falcons game scheduled for Thursday Night Football. The promotion provides a $50 reward token each day for five consecutive days if a…

SEPTEMBER 24, 20261 MIN
07REGULATORY

Weyerhaeuser outlines $1.5 billion EBITDA growth target for 2030

Weyerhaeuser Co. disclosed an accelerated growth strategy aimed at adding $1.5 billion in incremental Adjusted EBITDA to its results by 2030, measured against a 2024 baseline. The company presented these goals in an investor presentation…

SEPTEMBER 24, 20262 MIN
08HEALTH

Indonesian court blocks drug patent evergreening tactic

An Indonesian court struck down a legal provision that permitted patent evergreening, a strategy where pharmaceutical companies file new patents for minor changes to existing medicines to delay generic competition. The ruling marks a…

SEPTEMBER 24, 20261 MIN
09REGULATORY

Aptevo targets 2027 IND studies for lead trispecific APVO451

Aptevo Therapeutics Inc. is advancing its lead trispecific candidate, APVO451, toward clinical development by optimizing scalable manufacturing processes. The Seattle-based biotechnology company expects to begin Investigational New Drug…

SEPTEMBER 24, 20261 MIN

Why mornings start here

1642
Stories on the wire
every one dated and published on NewsDialy
12
Sections
distinct sections across the brief
2 min
Average story read
measured across everything we've filed

The 6:00 timeline

One scroll. The rest of the desk.

Tomorrow, 06:00

Start tomorrow already ahead.

One brief, every weekday, in your inbox before the world wakes up.